Predictors and impacts of second-line chemotherapy on survival after progression in patients with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Teramukai, S.
Nishimura, T.
Nakagawa, M.
Kawahara, M.
Kubota, K.
Furuse, K.
Fukushima, M.
机构：
[1] Kyoto Univ Hosp, Kyoto, Japan
[2] Natl Kinki Chuo Chest Med Ctr, Osaka, Japan
[3] Natl Canc Ctr Hosp East, Chiba, Japan
[4] Japan Multinatl Trial Org, Kyoto, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7675
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Ardizzoni, A
    Tiseo, M
    [J]. JOURNAL OF CHEMOTHERAPY, 2004, 16 : 104 - 107
  • [2] Predictors and Impact of Second-line Chemotherapy Administration for Advanced Non-small Cell Lung Cancer (NSCLC): Implications for the Consideration of Maintenance Chemotherapy
    Gerber, D. E.
    Rasco, D. W.
    Le, P.
    Yan, J.
    Xie, Y.
    Dowell, J. E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S534 - S534
  • [3] Efficacy of second-line nivolumab after early time to progression on first-line cytotoxic chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)
    Ota, T.
    Kirita, K.
    Udagawa, H.
    Umemura, S.
    Matsumoto, S.
    Yoh, K.
    Niho, S.
    Goto, K.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [4] Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer
    Hirata, Tsuyoshi
    Hakozaki, Taiki
    [J]. JOURNAL OF THORACIC DISEASE, 2023, 15 (07) : 3554 - 3556
  • [5] FREQUENCY OF SECOND-LINE CHEMOTHERAPY FOR ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Suzuki, Kensuke
    Kenmotsu, Hirotsugu
    Taira, Tetsuhiko
    Naito, Tateaki
    Kimura, Madoka
    Hisamatsu, Yasushi
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Shukuya, Takehito
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S484 - S484
  • [6] Second-line chemotherapy for non-small cell lung cancer
    Ruckdeschel, JC
    [J]. CHEST, 2006, 129 (04) : 840 - 842
  • [7] Second-line chemotherapy for non-small cell lung cancer
    De Marinis, F.
    De Santis, S.
    De Petris, L.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : V68 - V71
  • [8] Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer
    Cucevic, B
    Samarzija, M
    Baricevic, D
    Jakopovic, M
    Redzepi, G
    Samija, M
    [J]. COLLEGIUM ANTROPOLOGICUM, 2005, 29 (02) : 583 - 588
  • [9] The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
    Tucker, Steven
    [J]. CURRENT DRUG TARGETS, 2010, 11 (01) : 58 - 60
  • [10] Weekly docetaxel as a second-line treatment for advanced non-small cell lung cancer (NSCLC).
    García, R
    Pérez, P
    Alfonso, R
    Pérez-Manga, G
    Díaz-Rubio, E
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 116 - 116
12345